Clinical course of ulcerative colitis

Mario Cottone, Mario Cottone, Civitavecchia, Filippo Mocciaro, Scimeca, Giovanni Perricone, Ambrogio Orlando, Daniela Scimeca, Giuseppe Civitavecchia

Risultato della ricerca: Article

25 Citazioni (Scopus)

Abstract

. Dig Liver Dis. 2008 Jul;40 Suppl 2:S247-52.Clinical course of ulcerative colitis.Cottone M, Scimeca D, Mocciaro F, Civitavecchia G, Perricone G, Orlando A.Department of Medicine, Pneumology and Nutrition Clinic, V. Cervello Hospital,University of Palermo, Palermo, Italy.AIM: To provide a review of studies on prognosis in ulcerative colitis byreviewing the relevant population-based cohort studies. On the basis of incidenceand population studies, ulcerative colitis has a favourable clinical course, withgood quality of life, a chronic course characterized by at least one relapse, anda surgery rate of 30% after 10 years from diagnosis. Patients affected by severe ulcerative colitis have a higher risk of colectomy, and some clinical variablesmay predict the disease's clinical course. Most patients respond to steroids and only a low percentage become dependent, or non-responders to steroids. Patientswho have a long-lasting ulcerative colitis (>10 years) or are affected by anextensive disease have an increased risk of developing colorectal cancer, whilethose treated with immunosuppressants for long period of time may have anincreased risk of developing lymphomas. Data on mortality in ulcerative colitispatients are not homogeneous, but if a real risk exists it is in patients withextensive or severe disease. The evidence that patients with severe ulcerativecolitis are often non-smokers may explain why in one study the mortality rate waslower.
Lingua originaleEnglish
pagine (da-a)247-252
RivistaDefault journal
Volume40
Stato di pubblicazionePublished - 2008

Fingerprint

Ulcerative Colitis
Steroids
Pulmonary Medicine
Mortality
Colectomy
Immunosuppressive Agents
Italy
Population
Colorectal Neoplasms
Lymphoma
Cohort Studies
Quality of Life
Medicine
Recurrence
Liver

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cita questo

Cottone, M., Cottone, M., Civitavecchia, Mocciaro, F., Scimeca, Perricone, G., ... Civitavecchia, G. (2008). Clinical course of ulcerative colitis. Default journal, 40, 247-252.

Clinical course of ulcerative colitis. / Cottone, Mario; Cottone, Mario; Civitavecchia; Mocciaro, Filippo; Scimeca; Perricone, Giovanni; Orlando, Ambrogio; Scimeca, Daniela; Civitavecchia, Giuseppe.

In: Default journal, Vol. 40, 2008, pag. 247-252.

Risultato della ricerca: Article

Cottone, M, Cottone, M, Civitavecchia, Mocciaro, F, Scimeca, Perricone, G, Orlando, A, Scimeca, D & Civitavecchia, G 2008, 'Clinical course of ulcerative colitis', Default journal, vol. 40, pagg. 247-252.
Cottone M, Cottone M, Civitavecchia, Mocciaro F, Scimeca, Perricone G e altri. Clinical course of ulcerative colitis. Default journal. 2008;40:247-252.
Cottone, Mario ; Cottone, Mario ; Civitavecchia ; Mocciaro, Filippo ; Scimeca ; Perricone, Giovanni ; Orlando, Ambrogio ; Scimeca, Daniela ; Civitavecchia, Giuseppe. / Clinical course of ulcerative colitis. In: Default journal. 2008 ; Vol. 40. pagg. 247-252.
@article{85734b1bf05e4086984d99084f203a40,
title = "Clinical course of ulcerative colitis",
abstract = ". Dig Liver Dis. 2008 Jul;40 Suppl 2:S247-52.Clinical course of ulcerative colitis.Cottone M, Scimeca D, Mocciaro F, Civitavecchia G, Perricone G, Orlando A.Department of Medicine, Pneumology and Nutrition Clinic, V. Cervello Hospital,University of Palermo, Palermo, Italy.AIM: To provide a review of studies on prognosis in ulcerative colitis byreviewing the relevant population-based cohort studies. On the basis of incidenceand population studies, ulcerative colitis has a favourable clinical course, withgood quality of life, a chronic course characterized by at least one relapse, anda surgery rate of 30{\%} after 10 years from diagnosis. Patients affected by severe ulcerative colitis have a higher risk of colectomy, and some clinical variablesmay predict the disease's clinical course. Most patients respond to steroids and only a low percentage become dependent, or non-responders to steroids. Patientswho have a long-lasting ulcerative colitis (>10 years) or are affected by anextensive disease have an increased risk of developing colorectal cancer, whilethose treated with immunosuppressants for long period of time may have anincreased risk of developing lymphomas. Data on mortality in ulcerative colitispatients are not homogeneous, but if a real risk exists it is in patients withextensive or severe disease. The evidence that patients with severe ulcerativecolitis are often non-smokers may explain why in one study the mortality rate waslower.",
keywords = "ulcerative colittis.clinical course.",
author = "Mario Cottone and Mario Cottone and Civitavecchia and Filippo Mocciaro and Scimeca and Giovanni Perricone and Ambrogio Orlando and Daniela Scimeca and Giuseppe Civitavecchia",
year = "2008",
language = "English",
volume = "40",
pages = "247--252",
journal = "Default journal",

}

TY - JOUR

T1 - Clinical course of ulcerative colitis

AU - Cottone, Mario

AU - Cottone, Mario

AU - Civitavecchia, null

AU - Mocciaro, Filippo

AU - Scimeca, null

AU - Perricone, Giovanni

AU - Orlando, Ambrogio

AU - Scimeca, Daniela

AU - Civitavecchia, Giuseppe

PY - 2008

Y1 - 2008

N2 - . Dig Liver Dis. 2008 Jul;40 Suppl 2:S247-52.Clinical course of ulcerative colitis.Cottone M, Scimeca D, Mocciaro F, Civitavecchia G, Perricone G, Orlando A.Department of Medicine, Pneumology and Nutrition Clinic, V. Cervello Hospital,University of Palermo, Palermo, Italy.AIM: To provide a review of studies on prognosis in ulcerative colitis byreviewing the relevant population-based cohort studies. On the basis of incidenceand population studies, ulcerative colitis has a favourable clinical course, withgood quality of life, a chronic course characterized by at least one relapse, anda surgery rate of 30% after 10 years from diagnosis. Patients affected by severe ulcerative colitis have a higher risk of colectomy, and some clinical variablesmay predict the disease's clinical course. Most patients respond to steroids and only a low percentage become dependent, or non-responders to steroids. Patientswho have a long-lasting ulcerative colitis (>10 years) or are affected by anextensive disease have an increased risk of developing colorectal cancer, whilethose treated with immunosuppressants for long period of time may have anincreased risk of developing lymphomas. Data on mortality in ulcerative colitispatients are not homogeneous, but if a real risk exists it is in patients withextensive or severe disease. The evidence that patients with severe ulcerativecolitis are often non-smokers may explain why in one study the mortality rate waslower.

AB - . Dig Liver Dis. 2008 Jul;40 Suppl 2:S247-52.Clinical course of ulcerative colitis.Cottone M, Scimeca D, Mocciaro F, Civitavecchia G, Perricone G, Orlando A.Department of Medicine, Pneumology and Nutrition Clinic, V. Cervello Hospital,University of Palermo, Palermo, Italy.AIM: To provide a review of studies on prognosis in ulcerative colitis byreviewing the relevant population-based cohort studies. On the basis of incidenceand population studies, ulcerative colitis has a favourable clinical course, withgood quality of life, a chronic course characterized by at least one relapse, anda surgery rate of 30% after 10 years from diagnosis. Patients affected by severe ulcerative colitis have a higher risk of colectomy, and some clinical variablesmay predict the disease's clinical course. Most patients respond to steroids and only a low percentage become dependent, or non-responders to steroids. Patientswho have a long-lasting ulcerative colitis (>10 years) or are affected by anextensive disease have an increased risk of developing colorectal cancer, whilethose treated with immunosuppressants for long period of time may have anincreased risk of developing lymphomas. Data on mortality in ulcerative colitispatients are not homogeneous, but if a real risk exists it is in patients withextensive or severe disease. The evidence that patients with severe ulcerativecolitis are often non-smokers may explain why in one study the mortality rate waslower.

KW - ulcerative colittis.clinical course.

UR - http://hdl.handle.net/10447/31840

M3 - Article

VL - 40

SP - 247

EP - 252

JO - Default journal

JF - Default journal

ER -